Hi Rebecca,I'm so glad that you found your way to this board and this portfolio! I hear you, big-time, on the GMO issue. For one thing, MON will never find its way into this portfolio due to its many negative attributes, many of which you have mentioned. (I have written in the past about how MON is probably one of my LEAST favorite stock ideas.)I am also very much in favor of GMO labeling. I am myself distrustful of how much GMO (most importantly, GMO corn) has been included in our food supply without the benefit of simple labeling. I believe consumers have a right to know this and make their own decisions as to whether they want it or not. (I do know some people who are very much opposed to anti-GMO argument, for example, pointing out the recent data that came out lacked information like, corn in general isn't good for rats, but I digress). Regardless of which "side" is correct, I feel strongly about labeling and personally, don't really like the idea of using consumers as guinea pigs, which is how it has felt given the way rulemaking took place (MON's links to the FDA when GMO rules came up).That does bum me out that PEP made that stance, though sadly, it's probably not surprising. Unfortunately SRI is not a perfect world, and that's why I welcome people here to refute some of my picks and give their reasons why they don't believe certain companies are socially responsible.I should probably do an update on PEP soon, and this does remind me to do so as soon as possible.Thanks so much for your thoughts!Best,Alyce
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat